These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
3. Novel genetic immunotoxins and intracellular antibodies for cancer therapy. Chen SY; Marasco WA Semin Oncol; 1996 Feb; 23(1):148-53. PubMed ID: 8607024 [TBL] [Abstract][Full Text] [Related]
5. The development of immunotoxins for the therapy of cancer, AIDS, and immune dysfunctions. Vitetta ES Princess Takamatsu Symp; 1988; 19():333-40. PubMed ID: 3077626 [TBL] [Abstract][Full Text] [Related]
6. Specific targeting of cancer with monoclonal antibodies: diagnostic and therapeutic applications. Abrams PG; Morgan AC; Fritzberg R Cancer Invest; 1990; 8(2):287-8. PubMed ID: 2400950 [No Abstract] [Full Text] [Related]
7. Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations. Pimm MV Crit Rev Ther Drug Carrier Syst; 1988; 5(3):189-227. PubMed ID: 3060267 [TBL] [Abstract][Full Text] [Related]
8. Immunotoxins and cancer therapy. Li Z; Yu T; Zhao P; Ma J Cell Mol Immunol; 2005 Apr; 2(2):106-12. PubMed ID: 16191416 [TBL] [Abstract][Full Text] [Related]
9. The design of cytotoxic-agent-antibody conjugates. Ghose T; Blair AH Crit Rev Ther Drug Carrier Syst; 1987; 3(4):263-359. PubMed ID: 2435417 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of human tumor growth by intraperitoneal immunotoxins in nude mice. Marks A; Ettenson D; Bjorn MJ; Lei M; Baumal R Cancer Res; 1990 Jan; 50(2):288-92. PubMed ID: 2295069 [TBL] [Abstract][Full Text] [Related]
11. Medical applications of monoclonal antibodies. Clark MR Revis Biol Celular; 1986; 9():1-79. PubMed ID: 3324213 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies and immunoconjugates for cancer treatment. Baldwin RW; Byers VS Cancer Chemother Biol Response Modif; 1987; 9():409-31. PubMed ID: 3079412 [No Abstract] [Full Text] [Related]
17. Monoclonal antibodies for the treatment of cancer: therapeutic strategies. Houghton AN; Larson S Curr Opin Oncol; 1989 Dec; 1(2):258-65. PubMed ID: 2489969 [No Abstract] [Full Text] [Related]
18. Monoclonal antibodies: does sufficient selectivity to cancer cells exist for therapeutic application? Oldham RK J Biol Response Mod; 1987 Jun; 6(3):227-34. PubMed ID: 3298552 [No Abstract] [Full Text] [Related]
19. Genetically engineered monoclonal antibodies for direct anti-neoplastic treatment and cancer cell specific delivery of chemotherapeutic agents. Bodey B; Bodey B; Siegel SE; Kaiser HE Curr Pharm Des; 2000 Feb; 6(3):261-76. PubMed ID: 10637379 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates. Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]